Enterisol® Ileitis proved to be effective against Salmonella
The Paul Ehrlich Institute confirmed that Enterisol® Ileitis reduces prevalence of Salmonella infection and Salmonella seroprevalence at slaughter. The studies also showed that the oral administration of this live vaccine is leading to a modulation of the intestinal microbiome.
Boehringer Ingelheim partners with PetMedix
Boehringer Ingelheim announced a multi-year partnership with PetMedix to develop novel and transformative companion animal antibody therapeutics using PetMedix’s proprietary Ky9 platform.
